Supernus Announces Third Quarter 2019 Financial Results and Topline Data from Phase III Study of SPN-810 for Treatment of Impulsive Aggression (IA) in ADHD Patients

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. TAP
3. DELL
4. ROIV
5. ANET
6. NKE
7. PANW
8. CL
9. SNDK
10. EAT

Go back to Supernus Announces Third Quarter 2019 Financial Results and Topline Data from Phase III Study of SPN-810 for Treatment of Impulsive Aggression (IA) in ADHD Patients
SUPERNUS PHARM (NASDAQ: SUPN) Delayed: 43.53 -0.44 (1%)
Previous Close $43.97    52 Week High $26.84 
Open $43.66    52 Week Low $9.51 
Day High $44.11    P/E N/A 
Day Low $43.43    EPS $-2.62 
Volume 444,197